Subscribe By RSS
Recent Articles About Cephalon, Inc. (CEPH)
-
Cephalon Ests Up On Guidance
March 15 by: Zacks Investment ResearchEconomy Stocks
-
King Misses By A Penny
February 25 by: Zacks Investment ResearchEconomy Stocks
-
Label Expansion For BIIB’s Rituxan
February 22 by: Zacks Investment ResearchEconomy Stocks
-
Lower Q3 Loss For Alkermes
February 5 by: Zacks Investment ResearchEconomy Stocks
-
CEPH Enters Generics Market
February 2 by: Zacks Investment ResearchEconomy Stocks
-
Stocks To Watch On Tuesday 12 January
January 12 by: Antonio CostaStocks
-
Cephalon’s Nuvigil Under Pressure
January 7 by: Zacks Investment ResearchEconomy Stocks
-
Valeant Drug Accepted By FDA
January 4 by: Zacks Investment ResearchEconomy Stocks
-
FDA Delays Nuvigil Decision
December 28 by: Zacks Investment ResearchEconomy Stocks
-
Stock Market Briefs: Jabil Beats Earnings Expectations, Apple To Launch Internet TV Subscription
December 22 by: Zacks Investment ResearchFinancial Stocks Technology
-
Stocks Are Broadly Higher On Talk Of Further Stimulus And Kraft’s Cadbury Offer
November 9 by: OptionsXpressBiotech Consumer Staples Economy Financial Options Stocks Technology
-
Stock Picks And Trade Ideas For Thursday - RMBS, CEPH, DSX
February 5 by: Antonio CostaShipping Stocks Technology
